A Venture View of the J&J/Guidant Deal
Executive Summary
IN VIVO asked several leading medical device venture investors for their views on the impact of the Johnson & Johnson acquisition of Guidant Corp. on the device dealmaking landscape, with a special focus on opportunities for start-ups.